Hepatotoxicity of hypolipidemic drugs
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 7 (2) , 415-433
- https://doi.org/10.1016/s1089-3261(03)00024-2
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agentExpert Opinion on Investigational Drugs, 2000
- Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase InhibitorsClinical Pharmacokinetics, 1997
- Lovastatin-induzierte akute cholestatische HepatitisDeutsche Medizinische Wochenschrift (1946), 1995
- Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatinDigestive Diseases and Sciences, 1994
- The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐upJournal of Internal Medicine, 1994
- Case Report: Hepatitis and Hematemesis Complicating Nicotinic Acid UseThe Lancet Healthy Longevity, 1989
- HMG CoA Reductase InhibitorsDrugs, 1988
- Mechanism of Action and Biological Profile of HMG CoA Reductase InhibitorsDrugs, 1988
- An Overview of Lipid-Lowering DrugsDrugs, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987